Cloning of the CYP2J2 gene and identification of polymorphisms

被引：0
|
作者：
King, LM [1 ]
Ma, JX [1 ]
Srettabunjong, S [1 ]
Li, LP [1 ]
Zeldin, DC [1 ]
机构：
[1] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA
来源：
FASEB JOURNAL | 2000年 / 14卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
721
引用
收藏
页码：A1437 / A1437
页数：1
相关论文
共 50 条
  • [21] Haplotype analysis of the CYP2J2 gene associated with myocardial infarction in a Chinese Han population
    Zeng Jie
    Kong Hong
    Tao Jianhong
    Cheng Biao
    Zhou Yongmei
    Lai Jingchuan
    CELL BIOCHEMISTRY AND FUNCTION, 2010, 28 (06) : 435 - 439
  • [22] CYP2J2基因的研究进展
    王莉
    王永芹
    青海医药杂志, 2018, 48 (08) : 74 - 76
  • [23] Analysis of CYP2J2 mutations in the Chinese Uyghur population
    Li, Haiyue
    He, Yongjun
    Wang, Li
    Xing, Shishi
    Peng, Linna
    Yuan, Dongya
    Jin, Tianbo
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10871 - 10881
  • [24] CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk:: the Atherosclerosis Risk in Communities (ARIC) study
    Lee, Craig R.
    North, Kari E.
    Bray, Molly S.
    Couper, David J.
    Heiss, Gerardo
    Zeldin, Darryl C.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (05): : 349 - 358
  • [25] Potency and mechanism of CYP2J2 inhibition by major phytocannabinoids
    Yamaori, Satoshi
    Nagata, Yousuke
    Ohmori, Shigeru
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    DRUG METABOLISM REVIEWS, 2016, 48 : 89 - 89
  • [26] CHARACTERIZATION OF ANTIHYPERTENSIVE DRUGS AS POTENT INHIBITORS OF CYP2J2
    Yamaori, Satoshi
    Ikemura, Noriaki
    Kobayashi, Chinatsu
    Kamijo, Shinobu
    Ohmori, Shigeru
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S46 - S46
  • [27] Variability of CYP2J2 expression in human fetal tissues
    Gaedigk, Andrea
    Baker, Darren W.
    Totah, Rheem A.
    Gaedigk, Roger
    Pearce, Robin E.
    Vyhlidal, Carrie A.
    Zeldin, Darryl C.
    Leeder, J. Steven
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (02): : 523 - 532
  • [28] A comprehensive study revealed SNP–SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk
    Alexey V. Polonikov
    Irina V. Ponomarenko
    Marina A. Bykanova
    Svetlana S. Sirotina
    Anna V. Bocharova
    Kseniya V. Vagaytseva
    Vadim A. Stepanov
    Iuliia E. Azarova
    Mikhail I. Churnosov
    Maria A. Solodilova
    Hypertension Research, 2019, 42 : 257 - 272
  • [29] Genetic polymorphisms of CYP2S1, CYP2J2 and CYP2R1 genes in three Chinese populations: Han, Tibetan and Uighur
    Kang, Xing
    Shi, Hailong
    Zhang, Lirong
    Wang, Yanxia
    Zhang, Tingting
    Han, Min
    Chen, Chao
    Wang, Huijuan
    PHARMACOGENOMICS, 2018, 19 (12) : 961 - 977
  • [30] Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2
    Xu, Mei-juan
    Jiang, Li-feng
    Wu, Ting
    Chu, Ji-hong
    Wei, Yi-dan
    Aa, Ji-ye
    Wang, Guang-ji
    Hao, Hai-ping
    Ju, Wen-zheng
    Li, Ping
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 289 : 15 - 22
12345